Pere Fontova

Assistant Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pere Fontova is an Assistant Professor at the University of Barcelona, Spain. His research focuses on pharmacokinetics and drug metabolism, particularly in renal transplant recipients, exploring the optimization of tacrolimus dosing and the effects of genetic polymorphisms on drug exposure. Additionally, he investigates novel therapeutic agents with cytotoxic properties against cancer, including the mechanisms of action of small molecule carriers and autophagy inhibitors.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

A series of fluorescent coumarin-based bis-ureas have been synthesised. These compounds show strong HCl cotransport properties in model vesicle systems. Cellular localisation studies show that cytotoxic compound 4 localises in lysosomes and perturbs cellular pH.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

David Aguilà

Lecturer

University of Barcelona

SPAIN

View details

Juan Torras

Professor

University of Barcelona

SPAIN

View details

Philip A. Gale

University of Sydney

AUSTRALIA

View details

Vanessa Soto-Cerrato

Associate Professor

University of Barcelona

SPAIN

View details

Mohamed Fares (Metwaly)

Lecturer

University of Sydney

AUSTRALIA

View details

Nuria Montero

Associated Professor

University of Barcelona

SPAIN

View details

Lisanne van Merendonk

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

NETHERLANDS

View details

Ana Aurora Torres

Predoctoral Researcher - Formación Profesorado Universitario (FPU23/03130) | Ministerio de Ciencia, Innovación y Universidades

University of Barcelona

SPAIN

View details

JOSEP M CRUZADO

Professor

University of Barcelona

SPAIN

View details

Roberto Quesada

Universidad de Burgos

SPAIN

View details

ANA B. CABALLERO

Associate Professor

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pere Fontova

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes

A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death

Small molecule anion carriers facilitate lactate transport in model liposomes and cells

<i>CYP3A53</i> and <i>CYP3A422</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

Cytotoxicity of osmium(<scp>ii</scp>) and cycloosmated half-sandwich complexes from 1-pyrenyl-containing phosphane ligands

Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma

A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer

Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models

Collaborators (11)

David Aguilà

Juan Torras

Philip A. Gale

Vanessa Soto-Cerrato

Mohamed Fares (Metwaly)

Nuria Montero

Lisanne van Merendonk

Ana Aurora Torres

JOSEP M CRUZADO

Roberto Quesada

ANA B. CABALLERO

Make your next move.

Pere Fontova

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes

A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death

Small molecule anion carriers facilitate lactate transport in model liposomes and cells

<i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

Cytotoxicity of osmium(<scp>ii</scp>) and cycloosmated half-sandwich complexes from 1-pyrenyl-containing phosphane ligands

Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma

A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer

Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models

Collaborators (11)

David Aguilà

Juan Torras

Philip A. Gale

Vanessa Soto-Cerrato

Mohamed Fares (Metwaly)

Nuria Montero

Lisanne van Merendonk

Ana Aurora Torres

JOSEP M CRUZADO

Roberto Quesada

ANA B. CABALLERO

Make your next move.

<i>CYP3A53</i> and <i>CYP3A422</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach